Post-earnings recap
Reported
Thu, Feb 26, 2026
EPS actual
$-0.73
EPS est.
$-0.79
EPS surprise
+7.36%
1-day move
-1.09%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Rhythm Pharmaceuticals reported a wider-than-expected loss per share, which was somewhat offset by a positive surprise in EPS. However, the lack of revenue data and guidance left investors uncertain, contributing to a slight decline in the stock price. The management's defensive tone indicates they are facing challenges that may affect future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.73 | N/A | +7.36% |
| Revenue | N/A | N/A | N/A |
Overall, management expressed caution regarding future performance. They highlighted external factors impacting results.
Management noted ongoing challenges in the market.
They emphasized the need for strategic adjustments moving forward.